1. Home
  2. CDXC

CDXC

ChromaDex Corporation

Logo ChromaDex Corporation

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

as 04-19-2024 2:18pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.

Founded: N/A Country:
United States
United States
Employees: N/A City: LOS ANGELES
Market Cap: 296.0M IPO Year: N/A
Target Price: $6.00 AVG Volume (30 days): 297.3K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.07 EPS Growth: N/A
52 Week Low/High: $1.25 - $4.65 Next Earning Date: 05-08-2024
Revenue: $83,570,000 Revenue Growth: 15.99%
Revenue Growth (this year): 19.09% Revenue Growth (next year): 17.22%

Share on Social Networks: